Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-12-08 to 2024-01-02
Current total value of award: $48796.4
Description: 4563080750!TYSABRI 300 MG/15 ML VIAL 15ML